A

Apontis Pharma AG
XETRA:APPH

Watchlist Manager
Apontis Pharma AG
XETRA:APPH
Watchlist
Price: 11.25 EUR 2.27% Market Closed
Market Cap: 95.6m EUR

During the last 3 months Apontis Pharma AG insiders have not bought any shares, and have not sold any shares. The stock price has increased by 11% over this period (open performance analysis).

The last transaction was made on Dec 4, 2024 by Be Executive Gmbh (CEO) , who sold 10k EUR worth of APPH shares.

Last Transactions:
Be Executive Gmbh
CEO
€-10k
Milz, Thomas
Chief Commercial Officer (CCO)
€+9k
Be Executive Gmbh
CEO
€+8.9k
Zimmermann, Thomas
Chief Financial Officer (CFO)
€+10.1k
Zimmermann, Thomas
Chief Financial Officer (CFO)
€+3.4k
Zimmermann, Thomas
Chief Financial Officer (CFO)
€+1.7k
Zimmermann, Thomas
Chief Financial Officer (CFO)
€+1.7k
Reineke, Silke
Head of Marketing
€+36.6k
Milz, Thomas
Chief Commercial Officer (CCO)
€+14.4k
View All Transactions

During the last 3 months Apontis Pharma AG insiders have not bought any shares, and have not sold any shares. The stock price has increased by 11% over this period (open performance analysis).

The last transaction was made on Dec 4, 2024 by Be Executive Gmbh (CEO) , who sold 10k EUR worth of APPH shares.

Sold
0-3
months
0 EUR
0
3-6
months
10k EUR
1
6-9
months
0 EUR
0
9-12
months
0 EUR
0
Bought
0-3
months
No Insider Transactions
0
0 EUR
3-6
months
0
0 EUR
6-9
months
No Insider Transactions
0
0 EUR
9-12
months
3
34.7k EUR

Apontis Pharma AG
Insider Trading Chart

Apontis Pharma AG
Last Insider Transactions

Global
Insiders Monitor

Apontis Pharma AG
Glance View

Market Cap
93.7m EUR
Industry
Pharmaceuticals

APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

APPH Intrinsic Value
16.22 EUR
Undervaluation 31%
Intrinsic Value
Price
A

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top